Literature DB >> 29219190

Phenomenology, genetics, and CNS network abnormalities in laryngeal dystonia: A 30-year experience.

Andrew Blitzer1,2,3, Mitchell F Brin4,5, Kristina Simonyan6,7, Laurie J Ozelius7, Steven J Frucht2.   

Abstract

OBJECTIVE: Laryngeal dystonia (LD) is a functionally specific disorder of the afferent-efferent motor coordination system producing action-induced muscle contraction with a varied phenomenology. This report of long-term studies aims to review and better define the phenomenology and central nervous system abnormalities of this disorder and improve diagnosis and treatment.
METHODS: Our studies categorized over 1,400 patients diagnosed with LD over the past 33 years, including demographic and medical history records and their phenomenological presentations. Patients were grouped on clinical phenotype (adductor or abductor) and genotype (sporadic and familial) and with DNA analysis and functional magnetic resonance imaging (fMRI) to investigate brain organization differences and characterize neural markers for genotype/phenotype categorization. A number of patients with alcohol-sensitive dystonia were also studied.
RESULTS: A spectrum of LD phenomena evolved: adductor, abductor, mixed, singer's, dystonic tremor, and adductor respiratory dystonia. Patients were genetically screened for DYT (dystonia) 1, DYT4, DYT6, and DYT25 (GNAL)-and several were positive. The functional MRI studies showed distinct alterations within the sensorimotor network, and the LD patients with a family history had distinct cortical and cerebellar abnormalities. A linear discriminant analysis of fMRI findings showed a 71% accuracy in characterizing LD from normal and in characterizing adductor from abductor forms.
CONCLUSION: Continuous studies of LD patients over 30 years has led to an improved understanding of the phenomenological characteristics of this neurological disorder. Genetic and fMRI studies have better characterized the disorder and raise the possibility of making objective rather than subjective diagnoses, potentially leading to new therapeutic approaches. Laryngoscope, 128:S1-S9, 2018.
© 2017 The American Laryngological, Rhinological and Otological Society, Inc.

Entities:  

Keywords:  Laryngeal dystonia; botulinum toxin; dysphonia

Mesh:

Year:  2017        PMID: 29219190      PMCID: PMC5757628          DOI: 10.1002/lary.27003

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  66 in total

1.  Thyroarytenoid muscle responses to air pressure stimulation of the laryngeal mucosa in humans.

Authors:  Priyanka Bhabu; Christopher Poletto; Eric Mann; Steven Bielamowicz; Christy L Ludlow
Journal:  Ann Otol Rhinol Laryngol       Date:  2003-10       Impact factor: 1.547

2.  Adductor laryngeal dystonia (spastic dysphonia): treatment with local injections of botulinum toxin (Botox).

Authors:  M F Brin; A Blitzer; S Fahn; W Gould; R E Lovelace
Journal:  Mov Disord       Date:  1989       Impact factor: 10.338

Review 3.  Evidence for disturbances of copper metabolism in dystonia: from the image towards a new concept.

Authors:  G Becker; D Berg; M Francis; M Naumann
Journal:  Neurology       Date:  2001-12-26       Impact factor: 9.910

4.  Effects of botulinum toxin on pathophysiology in spasmodic dysphonia.

Authors:  S Bielamowicz; C L Ludlow
Journal:  Ann Otol Rhinol Laryngol       Date:  2000-02       Impact factor: 1.547

5.  Effects of botulinum toxin type A on intracortical inhibition in patients with dystonia.

Authors:  F Gilio; A Currà; C Lorenzano; N Modugno; M Manfredi; A Berardelli
Journal:  Ann Neurol       Date:  2000-07       Impact factor: 10.422

6.  An open-label study of sodium oxybate in Spasmodic dysphonia.

Authors:  Anna F Rumbach; Andrew Blitzer; Steven J Frucht; Kristina Simonyan
Journal:  Laryngoscope       Date:  2016-11-03       Impact factor: 3.325

7.  Botulinum toxin management of adductor spasmodic dysphonia after failed recurrent laryngeal nerve section.

Authors:  Lucian Sulica; Andrew Blitzer; Mitchell F Brin; Celia F Stewart
Journal:  Ann Otol Rhinol Laryngol       Date:  2003-06       Impact factor: 1.547

8.  Findings of multiple muscle involvement in a study of 214 patients with laryngeal dystonia using fine-wire electromyography.

Authors:  Darrell A Klotz; Nicole C Maronian; Patricia F Waugh; Ariana Shahinfar; Lawrence Robinson; Allen D Hillel
Journal:  Ann Otol Rhinol Laryngol       Date:  2004-08       Impact factor: 1.547

Review 9.  Sodium oxybate: a review of its use in alcohol withdrawal syndrome and in the maintenance of abstinence in alcohol dependence.

Authors:  Gillian M Keating
Journal:  Clin Drug Investig       Date:  2014-01       Impact factor: 2.859

10.  Functional characterisation of tetanus and botulinum neurotoxins binding domains.

Authors:  G Lalli; J Herreros; S L Osborne; C Montecucco; O Rossetto; G Schiavo
Journal:  J Cell Sci       Date:  1999-08       Impact factor: 5.285

View more
  11 in total

1.  The extrinsic risk and its association with neural alterations in spasmodic dysphonia.

Authors:  Laura de Lima Xavier; Kristina Simonyan
Journal:  Parkinsonism Relat Disord       Date:  2019-05-24       Impact factor: 4.891

2.  Acoustic Model of Perceived Overall Severity of Dysphonia in Adductor-Type Laryngeal Dystonia.

Authors:  Daniel P Buckley; Manuel Diaz Cadiz; Tanya L Eadie; Cara E Stepp
Journal:  J Speech Lang Hear Res       Date:  2020-07-16       Impact factor: 2.297

Review 3.  Electromyography of the posterior cricoarytenoid muscles: a consensus guideline.

Authors:  Gerhard Foerster; Adam Bach; Carmen Gorriz; Orlando Guntinas-Lichius; Kathleen Klinge; Matthias Leonhard; Claus Pototschnig; Berit Schneider-Stickler; Gerd Fabian Volk; Andreas H Mueller
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-04-30       Impact factor: 2.503

Review 4.  DYT-TUBB4A (DYT4 Dystonia): Clinical Anthology of 11 Cases and Systematized Review.

Authors:  Julien F Bally; Drew S Kern; Conor Fearon; Sarah Camargos; Francisco Pereira da Silva-Junior; Egberto Reis Barbosa; Laurie J Ozelius; Patricia de Carvalho Aguiar; Anthony E Lang
Journal:  Mov Disord Clin Pract       Date:  2022-04-28

Review 5.  The Patho-Neurophysiological Basis and Treatment of Focal Laryngeal Dystonia: A Narrative Review and Two Case Reports Applying TMS over the Laryngeal Motor Cortex.

Authors:  Maja Rogić Vidaković; Ivana Gunjača; Josipa Bukić; Vana Košta; Joško Šoda; Ivan Konstantinović; Braco Bošković; Irena Bilić; Nikolina Režić Mužinić
Journal:  J Clin Med       Date:  2022-06-15       Impact factor: 4.964

6.  DYT-TUBB4A (DYT4 Dystonia): New Clinical and Genetic Observations.

Authors:  Julien F Bally; Sarah Camargos; Camila Oliveira Dos Santos; Drew S Kern; Teresa Lee; Francisco Pereira da Silva-Junior; Renato David Puga; Francisco Cardoso; Egberto Reis Barbosa; Rachita Yadav; Laurie J Ozelius; Patricia de Carvalho Aguiar; Anthony E Lang
Journal:  Neurology       Date:  2020-09-17       Impact factor: 9.910

7.  Neural endophenotypes and predictors of laryngeal dystonia penetrance and manifestation.

Authors:  Sanaz Khosravani; Gang Chen; Laurie J Ozelius; Kristina Simonyan
Journal:  Neurobiol Dis       Date:  2020-12-11       Impact factor: 5.996

Review 8.  Laryngeal Dystonia: Multidisciplinary Update on Terminology, Pathophysiology, and Research Priorities.

Authors:  Kristina Simonyan; Julie Barkmeier-Kraemer; Andrew Blitzer; Mark Hallett; John F Houde; Teresa Jacobson Kimberley; Laurie J Ozelius; Michael J Pitman; Robert Mark Richardson; Nutan Sharma; Kristine Tanner
Journal:  Neurology       Date:  2021-04-15       Impact factor: 11.800

9.  Breathing dystonia in Meige syndrome.

Authors:  Natalie Anne Watson; Lucy Anne Hicklin; Marie-Helene Marion
Journal:  Clin Park Relat Disord       Date:  2021-08-28

Review 10.  Botulinum Toxin Therapy for Spasmodic Dysphonia in Japan: The History and an Update.

Authors:  Masamitsu Hyodo; Kahori Hirose; Asuka Nagao; Maya Nakahira; Taisuke Kobayashi
Journal:  Toxins (Basel)       Date:  2022-07-01       Impact factor: 5.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.